KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $690.0 million.

  • Teva Pharmaceutical Industries' Consolidated Net Income rose 35090.91% to $690.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 billion, marking a year-over-year increase of 25834.15%. This contributed to the annual value of $1.4 billion for FY2025, which is 17158.16% up from last year.
  • According to the latest figures from Q4 2025, Teva Pharmaceutical Industries' Consolidated Net Income is $690.0 million, which was up 35090.91% from $432.0 million recorded in Q3 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Consolidated Net Income peaked at $690.0 million during Q4 2025, and registered a low of -$1.8 billion during Q4 2023.
  • For the 5-year period, Teva Pharmaceutical Industries' Consolidated Net Income averaged around -$217.8 million, with its median value being -$43.5 million (2021).
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Consolidated Net Income plummeted by 128658.54% in 2022 and then soared by 35090.91% in 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Consolidated Net Income (Quarter) stood at -$151.0 million in 2021, then crashed by 783.44% to -$1.3 billion in 2022, then tumbled by 34.63% to -$1.8 billion in 2023, then surged by 84.69% to -$275.0 million in 2024, then skyrocketed by 350.91% to $690.0 million in 2025.
  • Its Consolidated Net Income was $690.0 million in Q4 2025, compared to $432.0 million in Q3 2025 and $281.0 million in Q2 2025.